ACH
Income statement / Annual
Last year (2025), Accendra Health Inc.'s total revenue was $2.76 B,
a decrease of 74.19% from the previous year.
In 2025, Accendra Health Inc.'s net income was -$1.10 B.
See Accendra Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$2.76 B |
$10.70 B |
$10.33 B |
$9.96 B |
$9.79 B |
$8.48 B |
$9.21 B |
$9.42 B |
$9.32 B |
$9.72 B |
| Cost of Revenue |
$1.56 B
|
$8.48 B
|
$8.21 B
|
$8.13 B
|
$8.27 B
|
$7.20 B
|
$8.08 B
|
$8.35 B
|
$8.15 B
|
$8.54 B
|
| Gross Profit |
$1.20 B
|
$2.22 B
|
$2.13 B
|
$1.83 B
|
$1.51 B
|
$1.28 B
|
$1.13 B
|
$1.07 B
|
$1.17 B
|
$1.19 B
|
| Gross Profit Ratio |
0.44
|
0.21
|
0.21
|
0.18
|
0.15
|
0.15
|
0.12
|
0.11
|
0.13
|
0.12
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.10 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$1.91 B
|
$0.00
|
$0.00
|
$0.00
|
$653.67 M
|
$602.67 M
|
$1.26 B
|
$427.98 M
|
$411.52 M
|
| Selling & Marketing Expenses |
$0.00
|
$17.85 K
|
$17.55 K
|
$16.41 K
|
$11.41 K
|
$389.00 M
|
$422.00 M
|
$0.00
|
$589.00 M
|
$558.90 M
|
| Selling, General & Administrative Expenses |
$1.05 B
|
$1.91 B
|
$1.81 B
|
$1.55 B
|
$1.08 B
|
$1.04 B
|
$1.02 B
|
$1.26 B
|
$1.02 B
|
$970.42 M
|
| Other Expenses |
-$2.42 M
|
$517.13 M
|
$207.09 M
|
$128.62 M
|
$55.59 M
|
$34.05 M
|
$30.67 M
|
$161.12 M
|
$65.64 M
|
$17.29 M
|
| Operating Expenses |
$1.05 B
|
$2.43 B
|
$2.02 B
|
$1.68 B
|
$1.14 B
|
$1.08 B
|
$1.06 B
|
$1.42 B
|
$1.08 B
|
$987.71 M
|
| Cost And Expenses |
$2.61 B
|
$10.91 B
|
$10.23 B
|
$9.81 B
|
$9.42 B
|
$8.28 B
|
$9.14 B
|
$9.73 B
|
$9.23 B
|
$9.50 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$129.20 M
|
$143.80 M
|
$157.92 M
|
$128.89 M
|
$48.09 M
|
$83.40 M
|
$98.11 M
|
$70.98 M
|
$31.77 M
|
$27.06 M
|
| Depreciation & Amortization |
$214.52 M
|
$264.78 M
|
$287.38 M
|
$228.67 M
|
$90.62 M
|
$83.14 M
|
$87.45 M
|
$83.40 M
|
$59.44 M
|
$55.39 M
|
| EBITDA |
$241.77 M |
$51.22 M |
$390.57 M |
$368.45 M |
$415.47 M |
$323.41 M |
$186.72 M |
-$272.71 M |
$209.40 M |
$279.67 M |
| EBITDA Ratio |
0.09
|
0
|
0.04
|
0.04
|
0.04
|
0.04
|
0.02
|
-0.03
|
0.02
|
0.03
|
| Operating Income Ratio |
0.05
|
-0.02
|
0.01
|
0.01
|
0.04
|
0.02
|
0.01
|
-0.04
|
0.01
|
0.02
|
| Total Other Income/Expenses Net |
-$252.11 M
|
-$149.59 M
|
-$159.23 M
|
-$132.02 M
|
-$91.72 M
|
-$94.21 M
|
-$101.87 M
|
-$74.75 M
|
-$31.77 M
|
-$27.06 M
|
| Income Before Tax |
-$101.95 M
|
-$357.36 M
|
-$54.73 M
|
$10.89 M
|
$276.75 M
|
$109.91 M
|
-$28.72 M
|
-$427.09 M
|
$57.48 M
|
$172.54 M
|
| Income Before Tax Ratio |
-0.04
|
-0.03
|
-0.01
|
0
|
0.03
|
0.01
|
-0
|
-0.05
|
0.01
|
0.02
|
| Income Tax Expense |
$729.00 K
|
$5.33 M
|
-$13.43 M
|
-$11.50 M
|
$55.17 M
|
$21.83 M
|
-$6.14 M
|
$32.43 M
|
-$15.32 M
|
$63.76 M
|
| Net Income |
-$1.10 B
|
-$362.69 M
|
-$41.30 M
|
$22.39 M
|
$221.59 M
|
$29.87 M
|
-$62.37 M
|
-$437.01 M
|
$72.79 M
|
$108.79 M
|
| Net Income Ratio |
-0.4
|
-0.03
|
-0
|
0
|
0.02
|
0
|
-0.01
|
-0.05
|
0.01
|
0.01
|
| EPS |
-14.31 |
-4.73 |
-0.54 |
0.3 |
3.05 |
0.47 |
-0.37 |
-7.28 |
1.2 |
1.76 |
| EPS Diluted |
-14.31 |
-4.73 |
-0.54 |
0.29 |
2.94 |
0.47 |
-0.37 |
-7.28 |
1.2 |
1.76 |
| Weighted Average Shares Out |
$76.90 M
|
$76.74 M
|
$75.79 M
|
$74.50 M
|
$72.74 M
|
$63.37 M
|
$60.57 M
|
$60.01 M
|
$60.00 M
|
$61.09 M
|
| Weighted Average Shares Out Diluted |
$76.90 M
|
$76.74 M
|
$75.79 M
|
$76.22 M
|
$75.49 M
|
$63.51 M
|
$60.57 M
|
$60.01 M
|
$60.00 M
|
$61.09 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
